Alnylam Pharmace. buy Biotechhunter
Start price
26.06.20
/
50%
€139.00
Target price
31.07.20
-
Performance (%)
-9.70%
End price
31.07.20
€125.52
Summary
This prediction ended on 31.07.20 with a price of €125.52. With a performance of -9.70%, the BUY prediction by Biotechhunter finished with a loss. Biotechhunter has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alnylam Pharmace. | 3.105% | 3.105% | -49.540% | 15.421% |
| iShares Core DAX® | -0.046% | 5.960% | 7.403% | 65.851% |
| iShares Nasdaq 100 | 0.922% | 3.693% | 28.138% | 93.298% |
| iShares Nikkei 225® | 3.014% | 6.638% | 48.886% | 89.079% |
| iShares S&P 500 | -0.359% | 2.747% | 22.530% | 71.942% |
Comments by Biotechhunter for this prediction
In the thread Alnylam Pharmace. diskutieren
Buy Alnylam Pharmace.